Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Non-monosymptomatic Nocturnal Enuresis in Children
NCT07398261Phase 3Active, not recruiting
- Sponsor
- Menoufia University
- Start
- Nov 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in nocturnal enuresis (NE), sponsored by Menoufia University. Started Nov 2023; status: active, not recruiting.
02
Drugs
mirabegron
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT07398261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398261.